Contact with many drugs and chemicals can produce glomerular injury. A common sign of such injury is proteinuria. Chemicals and drugs act through diverse mechanisms to produce injury, including direct damage to cellular and membranous glomerular components, as well ils to renal vasculature. Several basic pathophysiologic mechanisms, including the "intact nephron hypothesis" and the "hyperfiltration hypothesis," help to explain the mode of toxicity of many chemicals. Furthermore, they provide a means to understand the basis for renal damagc and the progression of renal disease once injury has occurred.
INTRODUCTION
Exposure to some drugs and chemicals can induce glomerular disease. Several excellent reviews have been written on this subject in recent years (I, 26, 49) and many papers have been published on the effects of specific chemical entities. The purpose of this paper is to give an overview of key features of chemically induced glomerular disease. Additionally, it is to present examples of compounds that damage glomeruli in different ways. Finally, the paper discusses some factors that influence healing or the progression of glomerular disease.
GLOMERULAR FUNCTIONS
Glomeruli perform a variety of important functions that are critical in maintaining homeostasis. These functions fall into 4 basic areas. First, and perhaps most important, the process of plasma ultrafiltration occurs in glomeruli, with removal of both plasma solutes (urea, glucose, electrolytes, to name a few) and plasma solvent (water). A description of this process has been the subject of many textbooks and is well described in them. Ultrafiltration is a vascular process and essentially, the kidney is a vascular filter, receiving approximately 25% of the cardiac output in most mammals. In humans, over 160 L of plasma are filtered every 24 hr.
Second, glomeruli also play a critical role in the regulation of blood pressure. Electrochemical and physical signals in the glomerulus stimulate secretion of a number of vasopressor agents like angiotensin, and, indirectly, hormones like aldosterone. Without critical and precise glomerular signaling, water and electrolyte balance would be impossible. Third, much of the circulation that invests the renal tubules is derived from the efferent arteriolar circulation. In this regard, glomerular activity regulates peritubular blood flow and therefore directly reg-ulates tubular metabolism. Obviously, when there is compromise of glomerular blood flow, the tubules are likewise compromised. Fourth, glomeruli play an important role in the removal of macromolecules from the circulation. One example of this is filtration and eventual destruction of circulating, soluble immune complexes and macromolecular aggregates of pathogenic material. In recent years, the phagocytic role of the mesangium has been extensively studied. PATHOPHYSIOLOGIC 
MECHANISMS OF GLOMERULAR INJURY
The renal response to injury, whether from infectious agents or from chemical exposure, can be predicted based on three theories or hypotheses. These are the "intact nephron" hypothesis, the "hyperfiltration" hypothesis, and the theory of complex deposition.
In 1960, Bricker et a1 proposed the "intact nephron" hypothesis (9) to attempt to explain a variety of observations about renal responses following acute injury. Bricker et a1 reiterated the well-known fact that the kidney is composed of a collection of structurally and functionally integrated units-nephrons. Each nephron functioned as a miniature kidney, performing diverse functions such as plasma filtration, control of systemic hydration, pH and electrolyte balance, elaboration of vasoactive hormones, and so fonh.
Following a series of studies in rats, and from observation of clinical cases of renal failure in humans, Bricker and coworkers proposed that, because nephrons were so architecturally complex and functionally integrated, damage to 1 portion of the nephron affected function of the entire nephron. For example, a primary glomerular disease like acute proliferative glomerulonephritis did not just affect the glomerulus but also altered peritubular blood flow, the stream of solutes and solvent presented downstream to the tubule, and all other tubular functions. It is readily apparent that compromised glomerular blood flow might also decrease the delivery of oxygen and other critical metabolites to the tubules, resulting in metabolic down regulation. Two consequences of this might be a loss of protein resorptive capacity in the proximal convoluted tubule and decreased synthetic activity (e.g., loss of conjugation of 1,25-dihydroxycholecalciferol or loss of erythropoietin production). By the same token, exposure of tubules to a toxin such as mercuric chloride or glycerol would lead not only to tubular epithelial cell necrosis but would decrease glomerular filtration via the tubuloglomerular feedback loop. This hypothesis removed any artificial division between glomerular and tubular disease-there was only nephron disease. Bricker and coworkers proposed that once nephrons were damaged, they were essentially lost from participation in renal function. Several events follow nephron injury. First, the nephron may be repaired and return to the population of intact nephrons contributing to the sum of renal functions. Second, the nephron may be irreversibly damaged and cease to participate in renal function. Third, after fetal development, the mammalian kidney has no potential to regenerate new nephrons in response to injury. The only means of compensating for nephron loss is for intact, undamaged nephrons to undergo morphologic and functional hypertrophy. However, the capacity of remnant intact nephrons to undergo hypertrophy is limited. Once nephron loss exceeds hypertrophic capacity, renal function will decline. One further consequence of nephron damage and loss was not described explicitly by the intact nephron hypothesis. This relates to replacement fibrosis, vascular compromise, and the progression of renal disease, discussed below. Based on nearly 4 decades of experimentation and observation, the intact nephron hypothesis has been proved almost in its entirety. It is considered to be a cornerstone of modem nephrology.
In 1982, Brenner and coworkers (8) proposed the "hyperfiltration" theory to explain the progressive nature of glomerular disease following injury and in aging. It is well known from observations of renal disease in hypertensive humans that progressive glomerulosclerosis is a common result of sustained hypertension. Sustained elevations of blood pressure damage delicate glomerular capillary beds by a variety of mechanisms not detailed here. Glomerulosclerosis can also be induced in experimental animals by manipulations that produce elevated blood pressure.
Building on these observations in hypertensive humans and experimental animals, Brenner and coworkers proposed that the primary cause of damage was transglomerular Iiyperfiltration, due to increased hydrostatic pressure in the glomerulus. By extension, they proposed that anything that caused glomerular hyperfiltration was deleterious to the kidney. Brenner noted that consumption of dietary protein produced a transient increase in glomerular filtration in any species, including man, and hypothesized that this was a primary factor in the development of glomerulosclerosis. Glomerular hyperfiltration was also seen in rats subjected to subtotal renal ablation and in those with induced diabetes mellitus. In both cases, rats developed progressive glomerulosclerosis.
In particular, Brenner and coworkers felt that dietary protein-associated transglomerular hyperfiltration was the fundamental basis for the progression of renal disease. They hypothesized that many mammals, such as humans and rats, evolved in an environment where food consumed had a relatively low protein content (vegetable matter and insects, for example). As a consequence of this pattern of feeding during evolution, these mammals were, hypothetically, not well adapted for changes in glomerular filtration following high protein feeding. Accordingly, humans and domesticated animals now live in an environment where daily consumption of dietary protein is high, leading to constant but transient elevations in transglomerular filtration that damage the kidney. It is obviously prudent to consider the potential impact of feeding high levels of protein to rats on chemical toxicity studies, where renal disease may be a significant problem.
The basis for much of Brenner's hypothesis is the study of rats that have undergone surgical renal ablation. Ablated rats fed high levels of protein develop progressive rodent nephropathy (PRN) and proteinuria at an accelerated rate, compared to nonablated rats fed the same level of protein or ablated rats fed a low-protein diet. Renal ablation obviously reduces the number of "intact" nephrons quickly (see above), and this technique forces remnant nephrons to undergo both functional and morphological hypertrophy, with increased single nephron glomerular filtration rate (SNGFR). Likewise, rats in which diabetes mellitus is induced with nephrotoxic, diabetogenic chemicals such as streptozotocin and that are fed a high protein diet also develop accelerated PRN, with sustained glomerular hyperfiltration following thickening of glomerular basement membranes, and gradual loss of "intact" nephrons.
Experimental observations made in rats support Brenner's hyperfiltration hypothesis as a basis for progressive glomerular disease. However, it is well known that many strains of rats develop age-related PRN, and this raises significant questions about the validity of this species as a model for renal disease in man or other mammals. Work done by us in dogs with surgically reduced renal mass does not support Brenner's observations made in rats (36). Dogs with three-quarters subtotal nephrectomy fed high levels of protein for 4 yr did not develop declining renal function nor the severe, progressive glomerular lesions that might be expected from Brenner's hypothesis. An understanding of the hyperfiltration hypothesis is important for understanding the deleterious effects of drugs and chemicals on glomeruli. It is clear that drugs and chemicals that produce hyperfiltration in the glomeruli of rats will accelerate the development and severity of PRN. This has been shown with compounds like puromycin aminonucleoside (PAN), adriamycin, and certain histamine-receptor antagonists (discussed below). Hyperfiltration may also play a role in the development of the progressive decline in glomerular function seen following administration of cyclosporin A (CycA; discussed below). Whether this hypothesis is a valid explanation for the progression of renal disease in all mammals remains to be proved conclusively.
The renal and systemic response to the deposition of macromolecules is a third mechanism of glomerular injury. Studies conducted over the past 4 decades have shown that the kidney is a primary site for the removal of macromolecules from the circulation. An important class of filtered macromolecules is soluble immune complexes. These molecules are combinations of antigen and specific antibodies that form in slight antigen or antibody excess. Antigen-excess complexes tend to form early in immunologic reactions, when antibody production is rising, but they are insufficient to cross-link antigens effectively and precipitate them from the circulation. Antibody-excess complexes form late in immunologic reactions, when there is a relative excess of antibody over available antigen. Such antibody-excess complexes are also unable to cross-link and precipitate effectively, are soluble, and circulate until filtered.
A wide variety of antigens has been identified in soluble complexes, including infectious agents, nucleoproteins, tissue degradation proteins and organelle fragments, tumor antigens, and some drugs like heroin.
Macromolecules lodge in the filtration apparatus as a consequence of ultrafiltration. The size, shape, and charge of macromolecules will determine whether they will be filtered and also where they deposit in the kidney. Some complexes, like brush-border antigens complexed with antibody, have a propensity to lodge directly beneath visceral epithelial cells, whereas others, like nucleoproteins and antinuclear antibodies deposit more readily under endothelial cells but within the glomerular basement membrane (GBM). Some macromolecules, such as noncomplexed immunoglobulin or renal tubular proteins, may be deposited within the mesangium, as the result of mesangial phagocytic activity, passive trapping, or binding with specific receptor molecules on glomerular cells. Some deposited immune complexes activate complement, initiating a sequence of inflammatory events. These events may include recruitment and localization of inflammatory cells at the site of complex deposition, release of inflammatory mediators and enzymes, and destruction of glomerular structures including the basement membrane, mesangium, and epithelial and endothelial cells. The deposition of some complexes may also stimulate intrusion of mesangial cell pseudopodia into capillary loops (mesangiocapillary glomerulonephritis) or cause epithelium and endothelium to produce excessive membrane material (membranous glomerulopathy). If glomerular structure cannot be reconstituted following inflammatory and proliferative events, glomeruli will become scarred and sclerotic. Clearly, such damaged glomeruli compromise nephron function and may be further injured by altered transglomerular hyperfiltration and perfusion shifting between nephron populations.
BASIC PATTERNS OF CHEhlICALLY INDUCED
GLOMERULAR INJURY Drugs and chemicals may damage glomeruli in several ways. Some drugs, such as puromycin aminonucleoside, adriamycin, and certain histamine-receptor antagonists cause direct injury to glomerular epithelial cells (1, 3, 4, 22, 37, 38). Other drugs, such as CycA, may alter renal blood flow and glomerular filtration, damage endothelial cells, and by doing so create a functional nephropathy with few acute morphologic alterations in glomeruli (13, 15, 28, 30, 33, 39, 44, 50, 51). As noted above, there are a large number of chemicals that damage glomeruli by stimulating the formation of antigen-antibody complexes, which lodge beneath epithelial cells in the GBM and incite inflammatoryhdaptive reactions. The best known of these drugs and chemicals are gold (1 1, 21, 29, 41, 46), mercuric chloride (2, 12, 48), and penicillamine (20, 24, 43).
Hydralazine and procainamide are 2 drugs that induce lupus erythematosus and the formation of antinuclear antibodies (3 1 ) . As such, they indirectly cause the formation of a variety of soluble immune complexes that lodge in GBM beneath endothelial cells or in the mesangium, disrupting filtration barrier integrity and inciting inflammation. A fifth broad category of chemically induced glomerular injury is caused by the induction of anti-basement membrane antibodies. Solvents like dry-cleaning fluid may solubilize or expose antigens on basement membranes that stimulate the production of antibody.
Binding of antibody to these antigens, followed by complement fixation and inflammatory reaction, destroys renal basement membranes and cells attached to them (49).
Glomeruli are also damaged as a consequence of tubulointerstitial disease, which also may be the result of direct tubular injury by chemicals or immune-mediated tubular disease secondary to chemical exposure (5,7, 14).
A comprehensive review of these forms of injury is beyond the scope of this paper.
Important and common features of chemically induced glomerular injury can be illustrated by a discussion of specific drugs and chemicals that produce disease.
CHEMICALS AND DRUGS THAT DAhf AGE GLOXIERULAR
EPITHELIAL CELLS A hallmark of drugs that damage glomerular epithelial cells is the induction of proteinuria (1, 10, 26). This is seen with several different drugs, discussed below.
PUROMYCIN AhlINONUCLEOSIDE
This drug was originally developed as an antibiotic that works by inhibition of protein synthesis at the level of the ribosome. Intravenous administration of PAN to rats (see below) produces glomerular dysfunction characterized by significant proteinuria. There are minimal morphologic lesions induced in glomeruli, until late in the course of disease. Monkeys are also sensitive to the effects of this drug and develop proteinuria following intravenous (iv) administration. Dogs, rabbits, mice, and guinea pigs are relatively insensitive to the nephrotoxic effects of PAN.
The glomerulopathy resulting from the administration of PAN is considered by many to be an excellent model for human minimal change disease, the major cause of proteinuria and focal sclerosis in children (10, 45).
Acute, reversible proteinuria can be induced by injection of PAN in the peripheral venous circulation in rats, at dose ranging from 0.5 to 1.5 mg/kg. Intraperitoneal (ip) injection of this compound will produce similar lesions. Within 24 hr of PAN administration, abnormalities can be detected in visceral epithelial cells by electron microscopy and selective proteinuria (albuminuria) de-velops. The primary lesion seen in visceral epithelial cells is effacement and retraction of epithelial cell foot processes (also termed "fusion") and formation of microfilamentous arrays within epithelial cells. Protein resorption droplets form in visceral epithelial cells. In some cases, the formation of large numbers of these droplets may lead to cell swelling and rupture, with denudation of GBM. Lesions seen by light microscopy in the early stages of this disease include very minimal thickening of GBM and the formation of scattered adherent synechia between capillary loops and Bowman's capsule (3, 4) .
Defects in the filtration apparatus are important contributors to the progression of lesions seen in this type of chemical glomerulopathy. Histochemical stains, such as Alcian blue, show a loss of filtration barrier anionic charge following the injection of PAN, a change confirmed using anionic molecules like negatively charged dextrans. The loss of barrier negative (anionic) charge allows the passage of negatively charged proteins (3, 22, 38) .
Barrier porosity to large molecules also changes (1). Following the administration of PAN, large neutral dextrans pass more freely through the damaged barrier.
Several studies have indicated that PAN administration alters the metabolism of key filtration barrier components. Decreased synthesis of filtration barrier proteoglycans and sialoglycoproteins has been noted in rats dosed with PAN and a loss of podocalyxin sialic acid content has been correlated with a loss of podocyte filtration slit organization. Some studies of PAN nephrosis indicate altered synthesis of type IV collagen, laminin, and fibronectin, all major components of the GBM (3, 4, 19, 22) .
Following peripheral iv or ip injection of PAN, proteinuria reaches a peak within 1-2 wk and then gradually subsides within 4 wk. Because there is transient and reversible proteinuria, the model created by peripheral iv or ip injection of PAN is considered an acute model for minimal change nephropathy.
The administration of PAN into the central venous circulation of rats at higher doses (5 mgkg) produces similar acute lesions and proteinuria, but proteinuria is persistent. This model of "chronic" proteinuria can also be induced by repeated subcutaneous administration of PAN. Rats dosed in this manner show decreased SNGFR, undoubtedly due to altered capillary filtration coefficient (4) .
Within 3 wk of induction of "chronic" PAN nephrosis, rats develop both subcutaneous edema and ascites, the result of hypoproteinemia (4). Extraglomerular lesions develop in tubules as the result of altered solvent and solute flow from damaged glomeruli and from altered perfusion. These include dilated tubular segments, protein casts within tubules, and hyalin droplet formation in tubular cell cytoplasm. Atrophy of .tubular epithelium occurs as a consequence of dilatation. In both the acute and chronic PAN models, acute glomerular lesions (seen with electron microscopy) progress to segmental glomerulosclerosis by 18-40 wk. Anderson et a1 (4) drawing from Brenner's hypothesis (S), inferred that the progression of glomerulosclerosis in rats given PAN was due to increased transglomerular filtration, hyperperfusion, and hypertension. They found that the administration of enalapril to rats given PAN prevented the development of accentuated focal glomerulosclerosis 70 wk after induction of nephrosis, suggesting that a reduction in hyperfiltration was protective.
ADRIAhlYCIN (DOXORUBRICIN)
The administration of adriamycin to rats or rabbits produces a protein-losing nephropathy similar to that induced by puromycin aminonucleoside. The use of this antineoplastic agent in man is not associated with primary renal lesions, but the drug is cardiotoxic.
Within a few days of adriamycin administration, rats develop proteinuria and associated abnormalities seen with electron microscopy (visceral epithelial cell foot process effacement and retraction, formation of proteinresorption droplets, and cell swelling). Defects in the integrity of the filtration barrier, similar to those seen in PAN nephrosis, are found in adriamycin nephrosis. The drug probenicid, used in the treatment of gout, also produces lesions similar to those of adriamycin (17, 42) . Minimal change nephropathy and nephrotic syndrome were noted in a patient exposed to the drug methimazole, being used as therapy for hyperthyroidism (34) .
HISTAhlINE-RECEPTOR ANTAGONISTS (ICI 125, 211; ICI 162, 846; CIMETIDINE) During the development of 2 gastric histamine type 2 receptor antagonists, we noted (37) that rats iv dosed with these compounds (designated ICI 125, 211 and ICI 162, 846) developed proteinuria within 2 wk of injection. The magnitude of proteinuria was proportional to the administered dose of compound. Rats sacrificed after 14-and 28-day iv dosing studies had no lesions by light microscopy but had characteristic lesions of minimal change nephropathy seen by electron microscopy. These lesions consisted of visceral epithelial cell foot process effacement and retraction into epithelial cell cytoplasm. Areas of effacement were, in some cases, extensive, completely covering the glomerular capillary basement membrane. We noted that the amount of foot process effacement was roughly correlated with the amount of urinary protein excreted. Oral administration of either compound also induced accentuated proteinuria in rats dosed continuously for periods of 3-6 mo. We did not note a significant number of protein-inclusion droplets in visceral epithelial cells, as was seen with puromycin administration, nor did we detect significant cell swelling and vacuolation, as seen with the latter.
In an attempt to clarify this effect, we administered a chemically dissimilar HZreceptor antagonist, cimetidine, to rats to see if it, too, would induce proteinuria. We found that when we administered cimetidine iv to rats, we produced similar electron microscopic lesions and associated proteinuria.
Rats dosed with ICI 125, 211 or ICI 162, 846 did not become azotemic or uremic despite persistent proteinuria.
Dogs dosed iv and orally with these compounds, for periods ranging from 2 wk to 6 mo, did not become azotemic or develop lesions, as assessed by light and electron microscopy. TOXICOLOGIC PATHOLOGY After 6 mo of oral dosing in rats with these compounds, we noted an increased incidence and severity of focal and segmental glomerulosclerosis and chronic progressive nephropathy in treated rats when compared to controls. This suggested to us that these compounds induced glomerular hyperfiltration and hyperperfusion in rats, accelerating the progression of spontaneously occurring rodent nephropathy.
Our work to elucidate the mechanisms underlying this nephropathy ended when both compounds proved to be gastric carcinogens in the rat, and development was terminated. N,N' -DIACETYLBENZIDINE Harman (16) described progressive proliferative glomerulonephritis, with crescent formation, and subsequent glomerulosclerosis, in rats fed N,N'-diacetylbenzidine. Female rats fed this compound developed accentuated and relatively nonspecific proteinuria within 2 wk, while male rats required approximately 2 mo before profound proteinuria occurred. Azotemia was seen in approximately 60% of exposed animals, and severe azotemia occurred in 30%.
Glomerular lesions are indicative of epithelial cell damage. Parietal epithelial cells proliferate and are vacuolated. These cells form obliterative crescents that compress glomerular capillary tufts. Crescents also form adhesions with capillary loops, and progressive sclerosis both of tufts and crescents develops over a period of 3-6 mo. One stimulus for crescent formation may be the presence of fibrin in Bowman's space.
Studies by Kirschbaum and Bosmann (23) have shown that N,N'-diacetylbenzidine also alters the activity of several key metabolic and synthetic enzymes in the renal cortex, some of which control glycoprotein synthesis. It is possible that some of the cytologic and membranous alterations induced by compound exposure are due to altered activities of glycosyltransferases.
Other drugs and chemicals that have a direct toxic effect on visceral epithelial cells or that indirectly injure these cells leading to proteinuria and/or glomerulopathy include urea (40) , fenoprofen (14) , and hexadimethrine (1).
CHEhllCALS AND DRUGS THAT ALTER RENAL
HEhlODYNAhlICS CycA is an immunosuppressive agent commonly used to prevent rejection of transplanted organs. Chronic administration of this drug produces renal dysfunction due to decreased renal perfusion, regardless of the clinical setting (heart, kidney, liver, and bone marrow transplantation).
In humans, characteristic renal lesions follow longterm use-(33). These lesions include vacuolation of tubular epithelium, formation of bands of interstitial fibrosis in the cortex, and development of prominent sclerotic lesions in hilar and interlobular arteries and arterioles. The most prominent vascular lesions are seen in afferent arterioles, where there is endothelial swelling, medial hyalinosis, and degeneration of medial smooth muscle cells. Such lesions lead to glomerulosclerosis and are consid-ered to be irreversible once established. The development of renal dysfunction is a primary reason for discontinuing cyclosporin therapy in man, with a resultant increased risk of transplant rejection. It is now thought that the loss of some renal transplants is not due to rejection, but rather to progressive, degenerative lesions induced by the administration of this drug.
Studies of the nephrotoxic effects of CycA have been conducted in a variety of experimental animals, including the rat and rabbit. Much of this work has concentrated on the basis for CycA effects on renal vasculature.
Infusion of the drug in isolated, perfused rat kidneys produces increased renal vascular resistance (RVR). Rossi and coworkers (39) found that decreased perfusion, following as a consequence of changes in RVR, could be effectively, but not completely, controlled by administration of calcium channel blockers like nifedipine and methoxyverapamil. Other investigators have noted that adrenergic blocking maneuvers can lessen the severity of CycA-induced increases in RVR.
Oral or iv administration of CycA decreases glomerular filtration rates (GFR) in rats. Perico et a1 (30) administered CycA to Sprague-Dawley rats for 45 days. These rats developed decreased GFR and increased serum creatinine. Rats also showed increased secretion of renin and activation of the renin-angiotensin system. Studies in man have supported the importance of renin-angiotensin activation in CycA toxicity. Sturrock and coworkers (44) found that pretreatment of normal human volunteers with furosemide, which activates the renin-angiotensin system, augmented CycA-induced renal vasoconstriction.
Perico and others also noted that the administration of CycA did not affect secretion of vasodilatory arachidonic derivatives, like prostacyclin and prostaglandin (PG)E2, 2 substances that would counter the vasoconstrictor effects of angiotensin. Recent studies by several groups suggest that CycA-induced decrements in GFR may be mediated by increased secretion of endothelin and thromboxane A2, 2 powerful vasoconstrictors (15) .
As noted above, chronic administration of CycA in man produces afferent arteriolar degeneration. The pathogenesis of this lesion was studied in salt-depleted rats given CycA (50) . Ten days after administration of CycA in a subcutaneous depot, rats developed subtle eosinophilic granularity in the cytoplasm of arteriolar smooth muscle cells. By 35 days, this progressed to focal vacuolation of smooth muscle cells and hyalinization of arterioles, lesions very similar to those seen in humans (28). English et a1 (13) showed, using scanning electron microscopy of renal vascular perfusion casts of rats treated with CycA, progressive decreases in the diameter of the afferent hilar arteriole. Zoja et a1 (51) found that the drug induced detachment and cytolysis of cultured bovine aorta endothelium, and this direct cytotoxic effect may contribute to CycA-induced vasculopathy.
Taken together, these observations in humans and in experimental animals show that cyclosporin has a unique mechanism for producing glomerular injury. Few compounds have a specific effect on specialized blood vessels. The consequences of a lesion in this critical arteriole are profound. Invoking, once again, Bricker's intact ne-phron hypothesis, we can see that decreased blood flow through the afferent arteriole compromises glomerular perfusion and function, as well as peritubular blood flow derived from the glomerular circulation. This altered perfusion is obviously a key factor in the secondary interstitial fibrosis that develops following chronic cyclosporin therapy. Furthermore, the loss of glomerulk perfusion is a key factor in the development of glomerulosclerosis. Finally, the effects of CycA are complex, operating through several pathways. It is clear that the drug will induce decreased glomerular perfusion, which in turn, stimulates the activity of the renin-angiotensin and other vasopressor systems. Increased vasopressor activity eventually may lead to glomerular hyperfiltration and hypertension, 2 key factors cited by Brenner et a1 as leading to glomerulosclerosis and progressive renal disease.
Other drugs like amphotericin B and gentamicin may also produce alterations in GFR by induction of alterations in capillary filtration co-efficient (1).
CHEhlICALS AND DRUGS THAT INDUCE IhlhlUNOLOGIC
REACTIONS THAT DAhlAGE THE KIDNEY There are a variety of ways in which immunologic reactions to drugs and chemicals can damage the kidney. Wilson (49), in his review of drug-and toxin-induced nephritis, notes that xenobiotics may form a portion of an immune complex, induce or be associated with lupus erythematosus, may induce the formation of immune complexes by facilitating antigen processing or antibody secretion, may induce cross-reactivity to renal antigens, or may induce the formation of anti-basement membrane antibodies. Several drugs and chemicals and mechanisms will be considered separately.
DRUGS AND CHEhlICALS IN IhlhlUNE COMPLEXES
It is well known that the injection of foreign proteins will stimulate the production of antibodies. In periods of antigen or antibody excess, when there is ineffective antigen cross-linking and precipitation, soluble complexes form, circulate, and are lodged in the renal ultrafiltration bamer. The injection of hyperimmune, animal-derived serum in humans was associated with formation of such soluble complexes and proliferative glomerulopathies. This mechanism has been extensively studied in animal models, particularly following injection of bovine serum albumin. Once lodged in glomerular capillary loops, complexes alter filtration properties and incite inflammation through the activation of complement.
Wilson (49) reports that the antibiotic carbenicillin may also induce antibody formation and form part of the soluble immune complexes that lodge in the kidney and incite glomerular inflammation and dysfunction. Likewise, the use of heroin has been associated with immune complex glomerulopathy, with the drug or contaminant components forming part of the complexes that lodge in glomeruli.
DRUGS AND CHEhlICALS ASSOCIATED WITH IhIhlUNE

COhlPLEX FORhl ATION D-Penicillmiiiie
D-Penicillamine is a drug used in the past to treat cystinuria, rheumatoid arthritis, and scleroderma. One com-plication of therapy with d-penicillamine is proteinuria and the development of nephrotic syndrome in patients receiving the drug (24, 26). Renal biopsies of several patients with nephrotic syndrome (20) showed that immunoglobulin and complement-containing deposits were lodged in GBMs. Electron microscopy confirmed the presence of electron-dense deposits in this location and irregular remodeling of GBM, associated with the presence of deposits. Discontinuation of drug therapy resulted in a decrease in immunoglobulin staining of membranes and membranous irregularities.
In several cases, the proliferation of mesangial cells and expansion of mesangial matrix were also noted. It is interesting to note that another drug used in the treatment of cystinuria, a-mercaptoproprionylglycine, also produced nephrotic syndrome in several patients (35) . It is unknown if this drug induces immune-complex formation.
Gold
Colloidal gold and gold salts have been used for over 20 yr for the treatment of rheumatoid arthritis. Kean and Anastassiades (21) noted that approximately 1.8% of patients on long-term chrysotherapy develop proteinuria. Proteinuria severe enough to produce nephrotic syndrome was seen in approximately 0.2% of patients on therapy, according to Silverberg et a1 (41) . Exposure to gold compounds induces membranous nephropathy, with numerous electron-dense deposits on glomerular basement membranes, when visualized with electron microscopy.
Granular deposits of immunoglobulin and complement can be seen with fluorescent microscopy. In the early stages of the disease and proteinuria, lesions in GBM are restricted to complex deposition. Subsequently, remodeling of the GBM occurs, with formation of layered membranes and the development of spikes on the GBM. By light microscopy, affected glomeruli show the development of typical membranous glomerulopathy (1 1, 41,  46) .
The pathogenesis of gold nephropathy is complex. Gold or substituents from formulation are not found in immune deposits. Several studies have looked for, but not found, rheumatoid factor in deposits, which might be suspected to be present in patients under treatment for rheumatoid arthritis. Palosuo and Milgrom (29) identified both dextran and anti-dextran antibodies in the deposits of patients with rheumatoid arthritis who are treated. They termed dextran as a "ubiquitous tissue antigen (UTA)," .suggesting that the deposition of gold within cells (such as those of the proximal tubule) liberated antigens that then formed complexes. They also suggested the possibility that dextrans are by-products of bacterial metabolism and structures, and that the source of UTA might be bacteria in oral and digestive cavities. It is probable that the immunosuppressive properties of gold and the altered activity of the immune system in rheumatoid arthritis and other "autoimmune" diseases may be important factors in the elaboration of soluble immune complexes.
Membranous nephropathy with characteristics very similar to those reported during chrysotherapy have been TOXICOLOGIC PATHOLOGY described in a severely burned patient treated with silver sulfadiazine and immunosuppressive agents, in a woman treated with ACE inhibitor captopril, and in patients treated with ammoniated mercurials (47) and the anti-epileptic medication trimethadione (6, 18) . Recently, a reversible membranous nephropathy, with epimembranous electrondense deposits, has been associated with the uSe of nonsteroidal anti-inflammatory drugs (fenoprofen, ibuprofen, nambumetone, naproxen, and tolmetin) (14, 32) .
Merciiric Chloride
The administration of mercuric chloride to experimental animals produces a biphasic glomerulopathy (2) . Rabbits that receive mercuric chloride develop diarrhea within 3-7 days of dosing and also elaborate antibodies to tubular (TBM) and glomerular (GBM) basement membranes. Antibody binding is also seen on coronary capillaries. While linear immunoglobulin can be detected on GBM during this phase, there is little complement deposition or inflammation. Within 4-10 wk, granular deposits of IgG and complement appear on GBM, with characteristic epimembranous electron-dense deposits seen by electron microscopy. At this stage, rabbits develop proteinuria and progressive membranous glomerulopathy. A similar presentation and progression of lesions is seen in Brown Norway rats dosed with mercuric chloride. Mice treated with this compound develop a mesangiocapillary glomerulonephritis, with intermittent deposits on GBM and in the mesangium.
Studies on the mechanism of this nephropathy suggest that the initial binding of compound to renal basement membranes and cellular substituents liberates unique antigens, and that these fuel the generation of immune complex formation, leading to the secondary phase of the disease. It is noteworthy that Brown Norway rats, which lack effective T-suppressor cell activity, are more prone to develop severe disease than other strains of rats. These rats may be more likely to produce abundant amounts of antibody, thereby fostering the production of soluble, rather than precipitating, immune complexes (12, 48) . Other metals may work in a similar manner (25, 27).
Procoinmiiide and Hydrolazine
A significant number of humans treated with procainamide or hydralazine develop lupus erythematosus, or elaborate antinuclear antibodies (ANAs), or do both, and some develop lupus or immune complex nephritis. Portanova and colleagues (31) studied this phenomena. They found that significant signs of lupus (arthralgia, myalgia, arthritis, pleuritis) were likely to develop within several weeks to months of beginning therapy. Withdrawal of the drugs produced a decrease in symptoms in many patients, but antinuclear antibodies were found to persist for long periods of time. Thirty percent of patients receiving hydralazine and 50% of patients receiving procainamide developed ANAS. In particular, these drugs facilitated the production of antibodies against various histones and single-stranded DNA.
In summary, it is likely that many more drugs and chemicals will be found or developed that cause glomer-ular injury by facilitating the development and deposition of antigen-antibody complexes.
CHEhlICALS AND DRUGS THAT CAUSE THE DEVELOPMENT
OF ANTI-GBM ANTIBODIES Fulminant, rapidly progressive, crescentic glomerulonephritis has been known to develop in a small percentage of workers with occupational exposure to certain hydrocarbon solvents. These occupational exposures occur with solvent contact during degreasing, painting, or refinishing of metal parts. Refinery workers with exposure to components of jet fuel and those who labor in drycleaning establishments are also at risk for the development of renal disease (49). The concurrent development of pulmonary lesions, including acute fulminant pneumonitis, has been termed Goodpasture's disease.
The initial stages in the pathogenesis of renal lesions following solvent exposure have not been determined but likely involve dissolution of portions of glomerular and pulmonary basement membrane collagen or the glycopeptide-enriched coating of the membranes. These membrane components stimulate the production of anti-BM antibodies, which subsequently bind to GBM and pulmonary membranes, activate complement, and induce a severe, acute, diffuse inflammatory response. It is the action of the sensitized immune system that destroys glomerular structures, leading to rapidly progressive renal failure. Characteristic linear deposits of IgG and complement are detected on GBM by fluorescent microscopy. Few lesions are seen in GBM with electron microscopy, and there is no deposition of immune complexes, as seen with exposure to other drugs. Damage to glomerular capillaries from enzymes secreted by infiltrating inflammatory cells leads to profound proteinuria and hematuria, with release of large proteins such as fibrin in Bowman's space. Crescentic proliferations of parietal epithelial cells follow exposure to fibrin and there is also proliferation of mesangial and visceral epithelial cells, in response to cell loss. It is likely that a cyclical immune and inflammatory reaction is responsible for the severity of lesions seen in this nephropathy. Lysis of membrane and death of glomerular cells liberates additional membrane-derived antigens that continue to evoke antibody production and binding and continued inflammation.
It is estimated that solvent exposure is a factor in the development of disease in 4-6% of all cases of human rapidly progressive glomerulonephritis. Attempts to induce this disease in rats by continuous exposure to vapors in unleaded gasoline were unsuccessful. SUMhlARY AND CONCLUSIONS Diverse chemicals and drugs can induce glomerular damage by a variety of pathogenetic mechanisms. Glomerular damage, in turn, leads to a loss of nephron function and significantly compromises blood flow to other nephron segments. Given the complexity of glomerular structure, there is limited opportunity for healing with a complete restoration of both structure and function. Drugand chemically induced lesions may lead to irreversible nephron loss and compensatory changes in remnant nephrons, including cellular and functional hypertrophy, as well as increased glomerular filtration and glomerular hypertension. This increase in glomeruladrenal perfusion may be deleterious to the kidney in some circumstances, setting up a cycle of sclerosis, progressive nephron loss, and renal fibrosis. It is advisable for all involved in the development and testing of drugs and chemicals to be cognizant of these complex relationships that .may lead to renal dysfunction and failure.
